ALLIANCEBERNSTEIN L.P. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,924,977
-72.1%
95,650
-73.4%
0.00%
-75.0%
Q1 2024$10,476,967
+7.5%
360,157
+1.9%
0.00%0.0%
Q4 2023$9,743,866
+231.7%
353,551
+169.7%
0.00%
+300.0%
Q3 2023$2,937,234
-46.6%
131,068
-3.1%
0.00%
-50.0%
Q2 2023$5,498,462
-65.1%
135,197
-58.4%
0.00%
-71.4%
Q1 2023$15,738,156
+18.3%
324,900
-6.8%
0.01%
+16.7%
Q4 2022$13,299,344
+112.2%
348,424
+179.0%
0.01%
+100.0%
Q3 2022$6,268,000
+69.0%
124,870
+34.9%
0.00%
+50.0%
Q2 2022$3,708,000
+7.4%
92,5500.0%0.00%
+100.0%
Q1 2022$3,453,000
-6.1%
92,550
+0.2%
0.00%0.0%
Q4 2021$3,678,000
+7.0%
92,3500.0%0.00%0.0%
Q3 2021$3,436,000
-12.5%
92,350
-0.6%
0.00%
-50.0%
Q2 2021$3,929,000
-95.2%
92,950
-94.6%
0.00%
-94.4%
Q1 2021$81,297,000
-24.9%
1,716,937
-3.2%
0.04%
-29.4%
Q4 2020$108,229,000
+33.2%
1,773,367
+2.0%
0.05%
+15.9%
Q3 2020$81,282,000
-3.7%
1,738,658
+4.5%
0.04%
-12.0%
Q2 2020$84,421,000
+18.2%
1,663,800
+3.9%
0.05%
-2.0%
Q1 2020$71,416,000
+1716.7%
1,600,887
+1855.9%
0.05%
+2450.0%
Q4 2019$3,931,000
+47.1%
81,850
+3.5%
0.00%0.0%
Q3 2019$2,673,000
-23.8%
79,050
+1.4%
0.00%0.0%
Q2 2019$3,508,000
+60.3%
77,950
+34.0%
0.00%
+100.0%
Q1 2019$2,189,000
-43.0%
58,150
-48.1%
0.00%
-66.7%
Q4 2018$3,842,000
+16.2%
111,950
+59.1%
0.00%
+50.0%
Q3 2018$3,306,000
+39.3%
70,3500.0%0.00%0.0%
Q2 2018$2,373,000
+77.8%
70,350
+42.6%
0.00%
+100.0%
Q1 2018$1,335,000
+62.2%
49,3500.0%0.00%0.0%
Q4 2017$823,000
-16.6%
49,3500.0%0.00%0.0%
Q3 2017$987,000
+9.1%
49,3500.0%0.00%0.0%
Q2 2017$905,000
+47.2%
49,350
-21.1%
0.00%
Q1 2017$615,000
-19.1%
62,550
-10.2%
0.00%
-100.0%
Q4 2016$760,000
-22.1%
69,6500.0%0.00%0.0%
Q3 2016$976,000
+83.8%
69,650
-7.9%
0.00%
Q2 2016$531,000
+56.2%
75,650
+43.4%
0.00%
Q1 2016$340,000
-99.2%
52,750
-95.9%
0.00%
-100.0%
Q4 2015$41,650,000
+51.3%
1,285,485
+24.7%
0.04%
+45.8%
Q3 2015$27,531,000
-26.9%
1,031,124
+31.7%
0.02%
-22.6%
Q2 2015$37,678,000
+190.7%
782,842
+267.5%
0.03%
+181.8%
Q1 2015$12,962,000
+649.7%
213,010
+537.8%
0.01%
+1000.0%
Q4 2014$1,729,000
+26.8%
33,400
+7.7%
0.00%0.0%
Q3 2014$1,364,000
+68.4%
31,0000.0%0.00%0.0%
Q2 2014$810,000
+26900.0%
31,000
+27578.6%
0.00%
Q1 2014$3,000
+50.0%
1120.0%0.00%
Q4 2013$2,0000.0%1120.0%0.00%
Q3 2013$2,0001120.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 319,444$8,644,00010.81%
RTW INVESTMENTS, LP 4,137,960$111,973,00010.66%
MAK CAPITAL ONE LLC 272,012$7,361,0009.24%
Boxer Capital, LLC 2,600,000$70,174,0007.49%
GREAT POINT PARTNERS LLC 1,539,822$41,668,000,0006.19%
SCOPIA CAPITAL MANAGEMENT LP 5,914,052$160,034,0003.20%
SECTORAL ASSET MANAGEMENT INC 437,934$11,850,0001.30%
Spark Investment Management LLC 655,500$17,737,0001.13%
Opaleye Management Inc. 145,000$3,923,0001.12%
Virtus ETF Advisers LLC 46,917$1,270,0001.10%
View complete list of PTC THERAPEUTICS INC shareholders